DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

LinksSchließen

Referenz

Okamoto A, Sugiyama T, Hamano T. et al.
Randomized phase III trial of paclitaxel/carboplatin (PC) versus cisplatin/irinotecan (CPT-P) as first-line chemotherapy in patients with clear cell carcinoma (CCC) of the ovary: A Japanese Gynecologic Oncology Group (JGOG)/GCIG study.

J Clin Oncol 2014;
32: 5507-5507

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: